국가: 아일랜드
언어: 영어
출처: HPRA (Health Products Regulatory Authority)
Foscarnet Sodium Hexahydrate
Tillomed Pharma GmbH
J05AD01
Foscarnet Sodium Hexahydrate
Solution for infusion
foscarnet
Not marketed
2022-08-12
PACKAGE LEAFLET PACKAGE LEAFLET: INFORMATION FOR THE USER FOSCARNET SODIUM HEXAHYDRATE TILLOMED 24 MG/ML SOLUTION FOR INFUSION foscarnet sodium hexahydrate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET? 1. What Foscarnet Tillomed is and what it is used for 2. What you need to know before you use Foscarnet Tillomed 3. How to use Foscarnet Tillomed 4. Possible side effects 5. How to store Foscarnet Tillomed 6. Contents of the pack and further information 1. WHAT FOSCARNET TILLOMED IS AND WHAT IT IS USED FOR Foscarnet Tillomed contains a medicine called foscarnet sodium hexahydrate. This belongs to a group of medicines called antivirals. It works by stopping viruses from multiplying in number. Foscarnet Tillomed is used to treat the following infections in AIDS patients: • A life-threatening or vision threatening eye infection called CMV retinitis caused by a virus in people with AIDS which leads to a loss of vision and eventually blindness. The virus is called cytomegalovirus (CMV) and the infection is known as CMV retinitis. Foscarnet Tillomed stops the infection from getting worse but it cannot repair the damage that has already happened. • Herpes Simplex Virus (HSV). Foscarnet Tillomed is given to people with HSV who have a weakened immune system. It is given to people who have not got better from HSV after having a medicine called aciclovir. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE FOSCARNET TILLOMED DO NOT USE FOSCARNET TILLOMED : - if you are allergic (hypersensitive) to foscarnet sodium hexahydrate or any of the other ingredients of this medicine (listed in section 6). If you are not sure, talk to your doctor or nurse before you 전체 문서 읽기
Health℃Products℃Regulatory℃Authority 12℃August℃2022 CRN009TDG Page℃1℃of℃11 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Foscarnet℃sodium℃hexahydrate℃Tillomed℃24℃mg/ml℃solution℃for℃infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each℃ml℃of℃solution℃for℃infusion℃contains℃24℃mg℃foscarnet℃sodium℃hexahydrate. Each℃250℃ml℃bottle℃contains℃6000℃mg℃foscarnet℃sodium℃hexahydrate℃ Each℃bottle℃of℃250℃ml℃contains℃1375℃mg℃(60℃mmol)℃sodium℃as℃a℃constituent℃of℃the℃active℃substance.℃ For℃the℃full℃list℃of℃excipients,℃see℃section℃6.1. 3 PHARMACEUTICAL FORM Solution℃for℃infusion Clear℃and℃colourless℃solution,℃practically℃free℃from℃particles℃ pH:℃Between℃7.2℃and℃7.6 Osmolality:℃Between℃240℃mOsmol/℃kg℃and℃300℃mOsmol/℃kg 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Foscarnet℃Tillomed℃should℃only℃be℃used℃in℃patients℃with℃acquired℃immunodeficiency℃syndrome℃(AIDS).℃ -℃Life℃threatening℃or℃eye-threatening℃disease℃caused℃by℃cytomegalovirus℃(CMV).℃Treatment℃with℃Foscarnet℃Tillomed℃should℃only be℃given℃if℃cytomegalovirus℃has℃been℃detected. -℃For℃acute,℃mucocutaneous℃infections℃caused℃by℃aciclovir-resistant℃herpes℃viruses℃(HSV).℃Foscarnet℃Tillomed℃therapy℃should℃be given℃if℃there℃are℃no℃medically℃acceptable℃therapeutic℃alternatives.℃Due℃to℃the℃risk℃profile℃of℃the℃active℃ingredient,℃a℃strict℃ indication℃is℃required. If℃there℃is℃a℃relapse,℃the℃aciclovir℃resistance℃must℃be℃reviewed. The℃generally℃accepted℃guidelines℃for℃the℃appropriate℃use℃of℃medicines℃to℃treat℃cytomegalovirus℃or℃herpes℃simplex℃infections℃in HIV-infected℃patients℃must℃be℃followed. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For℃intravenous℃application. _ _ _Posology_ CMV INFECTION: 전체 문서 읽기